Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04257474 · ClinicalTrials.gov registry record
Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk
A clinical trial, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Completed
- Registry status
- 265
- Enrollment target
NCT04257474: Completed study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
NCT04257474 is a clinical trial that has completed, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 265 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04257474 has completed, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- COMPLETED
- Registry status
- 265 participants
- Enrollment target
Study Summary
This study seeks to develop an explanatory framework for breast MRI utilization to inform future interventions. The Health Services Utilization Model (HSUM) will guide the selection of specific participant-level factors for examination, including predisposing characteristics (knowledge, health/cultural beliefs), enabling resources (social support, cost/insurance coverage), and perceived need (perceived susceptibility, provider recommendation).
Primary Outcome
Participant-reported receipt of screening breast MRI at any time in the past.
Interventions
- BEHAVIORAL Qualitative Interviews
- BEHAVIORAL Self-Report Survey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 265 participants |
| Start Date | 2020-01-30 |
| Est. Completion | 2022-01-19 |
What the finished NCT04257474 record still lists
NCT04257474 is an observational study that tracks outcomes without assigning an intervention. The registered 265 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which Qualitative Interviews is the first listed.
NCT04257474 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04257474 about?
NCT04257474 is a clinical study titled "Barriers to Screening Breast MRI Utilization Among Patients at Elevated Risk". This study seeks to develop an explanatory framework for breast MRI utilization to inform future interventions. The Health Services Utilization Model (HSUM) will guide the selection of specific participant-level factors for examination, including predisposing characteristics (knowledge, health/cultu...
What is the current status of trial NCT04257474?
This trial is currently completed. The enrollment target is 265 participants. The study started on 2020-01-30. Estimated completion is 2022-01-19.
What interventions are being tested in trial NCT04257474?
The interventions under investigation include: Qualitative Interviews (BEHAVIORAL), Self-Report Survey (BEHAVIORAL).
Who is sponsoring clinical trial NCT04257474?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05443126 · 265 participants · Phase 1
A Study of EP0031 in Patients With Advanced RET-altered Malignancies
- NCT05470491 · 265 participants · Phase 1
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
- NCT07301905 · 265 participants · NA
Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
- NCT07470853 · 265 participants · Phase 1
A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI